Molecular alterations assessed in brain tumors include IDH1/2 mutations, Histone H3F3A mutation, MGMT promoter methylation, TERT promoter methylation, EGFR amplification, ATRX retention or loss, and 1p/19q chromosomal co-deletion, for example. Here, EGFR is linked to brain neoplasm.